Category: Upcoming IPO

upcoming ipo, new ipo, upcoming ipo 2021, latest ipo, recent ipo, upcoming ipo list, upcoming ipo calendar, new ipo list, new ipo today, next ipo, forthcoming ipo, ipos today, new ipo launch, coming ipo, ipo watch upcoming ipo, upcoming ipo nse, upcoming ipo zerodha, latest ipo news, chittorgarh ipo,upcoming ipo chittorgarh,ipo watch upcoming ipo, ipowatch

Ruchi Soya FPO Date, Review, Price, Form & Market Lot Details

Upcoming IPO

Ruchi Soya FPO: Ruchi Soya Industries is established in 1986. It’s a Patanjali Group company, is one of the most well-known FMCG brands in the Indian edible oil industry. It is the largest maker of soya meals, having a presence in upstream and downstream industries, as well as secured palm plantations, spanning the whole value chain.

Read : Upcoming IPO

Promotors:- Acharya Balkrishna, Ram Bharat, Snehlata Bharat, Patanjali Ayurved Limited, Patanjali Parivahan Private Limited, Divya Yog Mandir Trust, Patanjali Gramudyog Nayas, Ruchi Soya Industries Limited Beneficiary Trust, Yogakshem Sansthan, Vedic Broadcasting Limited, Patanjali Peya Private Limited, Patanjali Natural Biscuits Private Ltd, Divya Packmaf Private Ltd, Vedic Ayurmed Pvt Ltd, Sanskar Info TV Pvt Ltd, Patanjali Agro India Pvt Ltd, SS Vitran Healthcare Pvt Ltd, Patanjali Paridhan Pvt Ltd, Gangotri Ayurveda Limited, Swasth Aahar Pvt Ltd, and Patanjali Renewable Energy Pvt Ltd are the promotors of the company.

Ruchi Soya FPO Date, Size & Price Band

IPO Opening Dates 24-March-2022
IPO Closing Dates 28-March-2022
Price Band 615-650 Rs
Offer For Sale Nil
Fresh issue 4,300 crore
Total size 4,300 crore
Minimum bid (lot size) 21 Shares
Face Value 2 Rs share
Retail Allocation 35%
Listing On NSE, BSE

Ruchi Soya FPO Market Lot

Lot No of Shares Amount
Minimum 1 21 13,650 ₹
Maximum 14 264 1,91,100 ₹

Financial Record of the last year (In Lakh)

Financial Period : 31-Dec-20
Total Assets : 8,55,879
Total Revenue : 11,52,347
Profit After Tax : 36,643
Earnings Per Share (EPS) FY2020 : 876.88 Rs

About Ruchi Soya:

Ruchi Soya Industries is one of the most well-known FMCG brands in the Indian edible oil industry. It is the largest maker of soya meals, having a presence in upstream and downstream industries, as well as secured palm plantations, spanning the whole value chain.

Edible oil and by-products, Oleochemicals, Textured Soya protein (TSP), Honey and Atta, Oil Palm Plantation, Biscuits, Cookies, and Rusks, Noodles and Breakfast cereals, Nutraceuticals and wellness, and Renewable energy wind power are some of the sectors in which the company operates.

Ruchi Soya FPO Allotment Date & Details

Allotment Date 5 April 2022
Initiation of refunds 6 April 2022
Transfer of shares to Demat accounts 7 April 2022
Listing Date 8 April 2022

Registrar of Ruchi Soya

Link Intime India Private Ltd
C 101, 247 Park, L.B.S.Marg,
Vikhroli (West), Mumbai – 400083
Phone: +91-22-4918 6270
Email: [email protected]
Website: http://www.linkintime.co.in

Ruchi Soya Contact Details

Ruchi Soya Industries Ltd
Ruchi House, Royal Palms, Survey No. 169,
Aarey Milk Colony, Near Mayur Nagar,
Goregaon (East), Mumbai 400 065
Phone: +91 22 6109 0100 / 200
Email: [email protected]
Website: http://www.ruchisoya.com/

Ruchi Soya Lead Managers

Axis Capital Limited
ICICI Securities Limited
SBI Capital Markets Limited

Ami Organics IPO GMP, Price, Review, Date

Upcoming IPO

Ami Organics is established in 2004 by Nareshkumar Ramjibhai Patel, Chetankumar Chhaganlal Vaghasia, Shital Nareshbhai Patel and Parul Chetankumar Vaghasia are the company promoters.

Ami Organics IPO: Ami Organics Limited is dedicated to optimize the utilization of healthcare resources and effectively meet your expectations of a comprehensive portfolio of varied products, custom synthesis, or contract manufacturing expertise in your prospective projects.

Ami Group was founded with the goal of converting reasonable money into specialty chemicals for Agrochemicals, Cosmetics, and Polymers.

Ami Organics Limited is committed to effectively meeting your expectations of a diverse product range, bespoke synthesis, or contract manufacturing in your potential projects. Ami Organics Limited now employs skilled and committed individuals who run cutting-edge manufacturing lines supported by advanced testing facilities and cutting-edge equipment.

They have expanded to provide New Chemical Entity (NCE) as well as large-scale delivery of pharmaceutical intermediates. We have established ourselves as a growing participant in the provision of pharmaceutical goods in line with GMP standards and a chemical manufacturing plant to serve our customers.

Ami Organics IPO Details
Subscription Dates 1-3 September 2021
Price Band 603 – 610 Rs Per Share
Offer For Sale 365.39-369.64 crore
Fresh issue 200 crore
Total IPO size 565.39 – 569.64 crore
Minimum bid (lot size) 24 Rs Share
Face Value 10 Rs share
Retail Allocation 35%
Listing On NSE, BSE
Ami Organics IPO Market Lot
Lot No of Shares Amount
Minimum 1 24 Shares 14,640 Rs
Maximum 13 312 Shares 1,90,320 Rs

Financial Record of the last year (In Million)

Financial Period : 31-Mar-21
Total Assets : 4,132.68
Total Revenue : 3,419.88
Profit After Tax : 539.99
Earnings Per Share (EPS) FY2021 : 17.14 Rs

Read :- Upcoming IPO

Ami Organic IPO Allotment Date & Details

Allotment Date 8 September 2021
Initiation of refunds 9 September 2021
Transfer of shares to Demat accounts 13 September 2021
Listing Date 14 September

Registrar of Ami Organic

Link Intime India Private Ltd
C 101, 247 Park, L.B.S.Marg,
Vikhroli (West), Mumbai – 400083
Phone: +91-22-4918 6270
Email: [email protected]
Website: http://www.linkintime.co.in

Ami Organics Contact Details

Ami Organics Limited
Plot No. 440/4, 5 & 6, Road No. 82/A
GIDC Sachin, Surat – 394 230
Phone: +91 261 239 7193
Email: [email protected]
Website: http://www.amiorganics.com/

Ami Organics Lead Managers

Ambit Private Limited
Axis Capital Limited
Intensive Fiscal Services Private Limited

FAQ Question

  • When is Ami Organics IPO Listing Date?

Ami Organics IPO listing date is 14-Sep 2021.

  • When Ami Organics IPO allotment?

Ami Organics IPO Allotment date is 8-Sep 2021.

  • What is Ami Organics IPO GMP ( Grey market premium) ?

Check latest IPO GMP

  • What is the lot size of Ami Organics IPO?

24 Shares Minimum.

  • How to apply in Ami Organics IPO through Zerodha?

1) Log in to Console on the Zerodha website.
2) Navigate to Portfolio and choose the IPOs link.
3) Click the ‘Bid’ button in the ‘Ami Organics IPO’ row.
4) Fill in your UPI ID, Quantity, and Price.
5) Fill out the IPO application form and click the “ Submit ” button.
6) To approve the mandate, go to the UPI App (net banking or BHIM).

  • How to check Ami Organics IPO Allotment?

User can check Ami Organics IPO Allotment on kfintech

  • How to check Ami Organics IPO Subscription Status?

User can check Ami Organics IPO Subscription Status on our website.

  • What is the Price band of Ami Organics IPO?

603 – 610 Rs.

  • What is the Issue Size of Ami Organics IPO?

565.39 – 569.64 Crore

Aptus Value Housing Finance IPO Date, Details, GMP , Review

Upcoming IPO

Aptus Value Housing Finance is established in 2009 by M. Anadan, Padma Anandan, and Westbridge Crossover Fund, LLC are the company founder.

Aptus Value Housing Finance IPO:-It is a retail-focused housing financing firm based in India that primarily targets low and middle-income self-employed clients in rural and semi-urban areas. According to CRISIL, it is one of the major home financing businesses in South India, with an AUM of 37,909.31 million as of December 31, 2020.

Competitive advantages

  • In terms of AUM, one of the largest housing financing businesses in South India.
  • A robust network of 181 branches spread over 75 districts and Puducherry’s union territory.
  • Presence in a huge, underserved market with significant growth potential.

    • Read :- Upcoming IPO 2021

    It has four production plants, three of which are in Tamil Nadu in Mettur, Berigai, and Cuddalore, and one in Puducherry at Karaikal.

    Aptus Value Housing Finance IPO details
    Subscription Dates 10-12 August 2021
    Price Band 346- 353 Rs Per Share
    Offer For Sale 2,280.05 crore
    Fresh issue 500 crore
    Total IPO size 2,780.05 crore
    Minimum bid (lot size) 42 Rs Share
    Face Value 2 Rs share
    Retail Allocation 35%
    Listing On NSE, BSE
    Aptus Value Housing Finance IPO Market Lot
    Lot No of Shares Amount
    Minimum 1 42 Shares 14,826 Rs
    Maximum 13 546 Shares 192,738 Rs

    Financial Record of the last year (In Million)

    Financial Period : 31-Mar-21
    Total Assets : 45,201.65
    Total Revenue : 6,552.42
    Profit After Tax : 2,669.44
    Earnings Per Share (EPS) FY2021 :-

    Registrar of Aptus Value Housing Finance

    KFintech Private Limited
    KFintech, Tower-B, Plot No 31 & 32,
    Financial District, Nanakramguda, Gachibowli,
    Hyderabad, Telangana India – 500 032.
    Phone: 04067162222, 04079611000
    Email: [email protected]
    Website: https://karisma.kfintech.com/

    Aptus Value Housing Finance Contact Details

    Aptus Value Housing Finance India Ltd
    No. 8B, Doshi Towers, 8th Floor, No: 205
    Poonamallee High Road, Kilpauk, Chennai 600 010
    Phone: +91 44 4565 0000
    Email: [email protected]
    Website: http://www.aptusindia.com/

    Aptus Value Housing Finance Lead Managers

    Citigroup Global Markets India Private Limited
    Edelweiss Financial Services Ltd
    ICICI Securities Limited
    Kotak Mahindra Capital Company Limited

    Chemplast Sanmar IPO Date, Details , GMP, Review

    Upcoming IPO

    Chemplast Sanmar Limited is established in 1985 by Sanmar Holdings Limited are the company founder.

    Chemplast Sanmar IPO :- It is one of India’s major speciality chemical manufacturers. The firm produces specialized paste PVC resin, starting materials, and intermediates for the agrochemical, pharmaceutical, agro-chemical, and fine chemical industries. It also manufactures Caustic Soda, Chlorochemicals, Hydrogen Peroxide, Refrigerant Gas, and Industrial Salt.

    Competitive advantages

  • In terms of installed production capacity, it is India’s largest maker of specialty paste PVC resins.
  • South India’s third-biggest manufacturer of caustic soda and its largest manufacturer of hydrogen peroxide.
  • A subsidiary of the SHL Chemicals Group, one of South India’s most important business conglomerates.

    • Read :- Upcoming IPO 2021

    It has four production plants, three of which are in Tamil Nadu in Mettur, Berigai, and Cuddalore, and one in Puducherry at Karaikal.

    Chemplast Sanmar IPO details
    Subscription Dates 10-12 August 2021
    Price Band 530- 541 Rs Per Share
    Offer For Sale 2550 crore
    Fresh issue 1,300.00 crore
    Total IPO size 3,850.00 crore
    Minimum bid (lot size) 27 Rs Share
    Face Value 5 Rs share
    Retail Allocation 35%
    Listing On NSE, BSE
    Chemplast Sanmar IPO Market Lot
    Lot No of Shares Amount
    Minimum 1 27 Shares 14,607 Rs
    Maximum 13 351 Shares 189,891 Rs

    Financial Record of the last year (In Million)

    Financial Period : 31-Mar-21
    Total Assets : 44,860.93
    Total Revenue : 38,151.08
    Profit After Tax : 4,102.44
    Earnings Per Share (EPS) FY2021 :30.60 Rs

    Registrar of Chemplast Sanmar

    KFintech Private Limited
    KFintech, Tower-B, Plot No 31 & 32,
    Financial District, Nanakramguda, Gachibowli,
    Hyderabad, Telangana India – 500 032.
    Phone: 04067162222, 04079611000
    Email: [email protected]
    Website: https://karisma.kfintech.com/

    Chemplast Sanmar Contact Details

    Company Contact Information
    Chemplast Sanmar Limited
    9, Cathedral Road, Chennai, 600086
    Phone: + (91) 44 28128500
    Email: [email protected]
    Website: http://www.chemplastsanmar.com/

    CarTrade IPO Date, Details, Price, GMP

    Upcoming IPO

    CarTrade Tech Limited is established in 2000 by Vinay Sanghi and Rajan Mehra are the company founder.Currently, There is a well-managed firm with no visible promoters.

    CarTrade IPO :- It is a provider of multi-channel vehicle platforms. The platform links new and used car buyers, vehicle dealers, vehicle OEMs, and other companies to purchase and sell various sorts of automobiles.

    The firm provides a wide range of automobile transaction solutions for purchasing, selling, marketing, financing, and other operations. A company having good online platforms like CarWale, CarTrade, Shriram Automall, BikeWale, CarTradeExchange, Adroit Auto, and AutoBiz ext.

    Competitive advantages

  • Profitable Business Model.
  • Having good market ratio in used car segment over the country.

    • Read :- Upcoming IPO 2021

    CarTrade IPO details
    Subscription Dates 9-11 August 2021
    Price Band 1585- 1618 Rs Per Share
    Offer For Sale 2,998.51 crore
    Fresh issue 0 crore
    Total IPO size 2,998.51 crore
    Minimum bid (lot size) 9 Rs Share
    Face Value 10 Rs share
    Retail Allocation 35%
    Listing On NSE, BSE
    CarTrade IPO Market Lot
    Lot No of Shares Amount
    Minimum 1 9 Shares 14,562 Rs
    Maximum 13 117 Shares 189,306 Rs

    Financial Record of the last year (In Million)

    Financial Period : 31-Mar-21
    Total Assets : 19,301.99
    Total Revenue : 2,815.23
    Profit After Tax : 1,010.74
    Earnings Per Share (EPS) FY2021 :19.19 Rs

    Registrar of CarTrade IPO

    Link Intime India Private Limited
    C-101, 1st Floor, 247 Park
    Lal Bahadur Shastri Marg,
    Vikhroli (West) Mumbai – 400 083
    Phone: +91 22 4918 6200
    Fax: +91 22 4918 6195
    Website: http://www.linkintime.co.in

    CarTrade Contact Details

    CarTrade Tech Limited
    12th Floor, Vishwaroop IT Park, Sector 30A
    Vashi, Navi Mumbai 400 705, Maharashtra, India
    Phone: +91 22 6739 8888
    Website: http://www.cartradetech.com/

    CarTrade Tech IPO Lead Managers

    Axis Capital Limited
    Citigroup Global Markets India Private Limited
    Kotak Mahindra Capital Company Limited
    Nomura Financial Advisory And Securities (India) Pvt Ltd

    Windlas Biotech IPO Date, Details, Price, GMP

    Upcoming IPO

    Windlas Biotech Limited is established in 2001 by Ashok Kumar Windlass, Hitesh Windlass, Manoj Kumar Windlass, and AKW WBL Family Pvt Trust are the company promoters.

    Windlas Biotech IPO It is one of India’s major pharmaceutical formulations contract development and manufacturing organizations (CDMO). The firm provides CDMO services ranging from product discovery to product development, licensing, and commercial manufacture of generic products, including complex generics.

    Windlas Biotech’s major customers include Pfizer Ltd, Sanofi India Ltd, Cadila Healthcare Ltd, Emcure Pharmaceuticals Ltd, Eris Lifesciences Ltd, Intas Pharmaceuticals Ltd, and Systopic Laboratories Private Limited.

    Check :- Upcoming IPO 2021

    Its production facilities are in Dehradun and have an installed capacity of 7,063.83 million tablets/capsules, 54.46 million pouches/sachets, and 61.08 million liquid bottles.

    Windlas Biotech IPO details
    Subscription Dates 4-6 Aug 2021
    Price Band 448 – 460 Rs Per Share
    Offer For Sale 236.54 crore
    Fresh issue 165 crore
    Total IPO size 401.54 crore
    Minimum bid (lot size) 30 Rs Share
    Face Value 5 Rs share
    Retail Allocation 35%
    Listing On NSE, BSE
    Windlas Biotech Limited Market Lot
    Lot No of Shares Amount
    Minimum 1 30 Shares 13,800 Rs
    Maximum 14 420 Shares 193,200 Rs

    Financial Record of the last year (In Million)

    Financial Period : 31-Dec-20
    Total Assets : 3,158.83
    Total Revenue : 3,230.94
    Profit After Tax : 96.74
    Earnings Per Share (EPS) FY2021 : 8.70

    Registrar of Windlas Biotech Limited IPO

    Link Intime India Private Limited
    C-101, 1st Floor, 247 Park
    Lal Bahadur Shastri Marg,
    Vikhroli (West) Mumbai – 400 083
    Phone: +91 22 4918 6200
    Fax: +91 22 4918 6195
    Website: http://www.linkintime.co.in

    Windlas Biotech Limited Contact Details

    Windlas Biotech Limited
    40/1, Mohabewala Industrial Area,
    Dehradun, 248110
    Phone: +91 135 6608000
    Website: http://www.windlasbiotech.com/

    Windlas Biotech IPO Lead Managers

    SBI Capital Markets
    DAM Capital Advisors
    IIFL Securities Ltd

    Exxaro Tiles IPO Date, Details, Price, GMP

    Upcoming IPO

    Exxaro Tiles Limited is established in 2008 by Mr. Mukeshkumar Patel, Mr. Kirankumar Patel, Mr. Dineshbhai Patel, and Mr. Rameshbhai Patel are the company promoters.

    Exxaro Tiles IPO It is involved in the production and sale of vitrified tiles. Double Charge Vitrified Tiles (double layer pigment) and Glazed Vitrified Tiles are manufactured from ceramic elements such as clay, quartz, and feldspar. Its product line includes over 1000 distinct tile designs in 6 sizes. Some of the company’s well-known products are the Topaz Series, Galaxy Series, and High Gloss Series.

    Read :- Upcoming IPO 2021

    Its goods are used in big infrastructure projects such as residential, educational, commercial, hotels, hospitals, government, builders or developers, religious organizations, and so on. It also sells tiles to many nations across the world, including Poland, Bosnia, the United States, and others.

    Competitive advantages

  • A variety of vitrified tile design options in various sizes are available.
  • With over 2,000 registered dealers, the company has a large dealer network.
  • PAN India has a strong presence in all 27 Indian states.
  • International presence, with exports to over 13 countries worldwide.
    • Exxaro Tiles IPO details
    Subscription Dates 4-6 2021
    Price Band 118-120 Rs Per Share
    Offer For Sale 26.86 crore
    Fresh issue 134.23 crore
    Total IPO size 161.09 crore
    Minimum bid (lot size) 125 Rs Share
    Face Value 10 Rs share
    Retail Allocation 35%
    Listing On NSE, BSE
    Exxaro Tiles IPO Market Lot
    Lot No of Shares Amount
    Minimum 1 125 Shares 15,000 Rs
    Maximum 13 1625 Shares 195,000 Rs

    Financial Record of the last year (In Million)

    Financial Period : 31-MAR-21
    Total Assets : 3,693.14
    Total Revenue : 2,598.53
    Profit After Tax : 152.23
    Earnings Per Share (EPS) FY2020 : 3.36 Rs

    Registrar of Exxaro Tiles IPO

    Link Intime India Private Limited
    C-101, 1st Floor, 247 Park
    Lal Bahadur Shastri Marg,
    Vikhroli (West) Mumbai – 400 083
    Phone: +91 22 4918 6200
    Fax: +91 22 4918 6195
    Website: http://www.linkintime.co.in

    Exxaro Tiles Contact Details

    Exxaro Tiles Limited
    Survey No. 169 & 170, Vavdi Harsol Road, At & Po.
    Mahelav, Taluka: Talod, Sabarkantha – 383 305
    Phone: +02772-350555
    Website: http://www.exxarotiles.com/

    Exxaro Tiles IPO Lead Managers

    Pantomath Capital Advisors Pvt Ltd

    Krsnaa Diagnostics IPO Date, Details, Price, GMP

    Upcoming IPO

    Krsnaa Diagnostics is established in 2010 by Rajendra Mutha is the company founder.

    krsnaa Diagnostics IPO : It is one of India’s fastest-growing diagnostic chains. The firm provides a comprehensive variety of diagnostic services to private and governmental hospitals, medical colleges, and community health centers, including imaging/radiology services (X-rays, MRI, etc.), regular clinical laboratory testing, pathology, and teleradiology services.

    Krsnaa Diagnostics IPO details
    Subscription Dates 4-6 August 2021
    Price Band 933 -954 Rs Per Share
    Offer For Sale 813.33 crore
    Fresh issue 400 crore
    Total IPO size 1,213 crore
    Minimum bid (lot size) 15 Rs Share
    Face Value 5 Rs share
    Retail Allocation 35%
    Listing On NSE, BSE
    Krsnaa Diagnostics IPO Market Lot
    Lot No of Shares Amount
    Minimum 1 15 Shares 14,310 Rs
    Maximum 13 195 Shares 1,86,030 Rs

    Financial Record of the last year (In Million)

    Financial Period : 31-Dec-20
    Total Assets : 6,345.17
    Total Revenue : 5,627.01
    Profit After Tax : 1,959.30
    Earnings Per Share (EPS) FY2021 : -97.16 RS

    Registrar of Krsnaa Diagnostics IPO

    KFintech Private Limited
    KFintech, Tower-B, Plot No 31 & 32,
    Financial District, Nanakramguda, Gachibowli,
    Hyderabad, Telangana India – 500 032.
    Phone: 04067162222, 04079611000
    Website: https://karisma.kfintech.com/

    Krsnaa Diagnostics Contact Details

    Krsnaa Diagnostics Limited
    S.No. 243, A-Hissa No. 6, CTS No. 4519, 4519/1,
    Chinchwad, Taluka – Haveli, Pune – 411 019
    Phone: +91 20 4695 4695
    Website: https://krsnaadiagnostics.com/

    Krsnaa Diagnostics Lead Managers

    DAM Capital Advisors Ltd (Formerly IDFC Securities Ltd)
    Equirus Capital Private Limited
    IIFL Holdings Limited
    JM Financial Consultants Private Limited

    Nuvoco Vistas IPO Date, Details, GMP, Review

    Upcoming IPO

    Nuvoco Vistas Corporation Ltd is established in 1999 by Niyogi Enterprises Pvt Ltd and Dr. Karsanbhai K Patel are the company promoters.

    Nuvoco Vistas IPO:- It is a Subsidiary of the Nirma Group. Nuvoco Vistas is one of India’s major concrete makers.It provides a diverse range of goods, including cement, Ready-mix Concrete (RMX), and contemporary building supplies such as adhesives, wall putty, dry plaster, cover blocks, and more.

    Check :- Upcoming IPO 2021

    The company offers its products in two markets: trade (individual house purchasers) and non-trade (other businesses) (institutional and bulk buyers). It has a robust distribution network that includes 15,969 dealers and 225 CFAs.

    Its cement facilities have an aggregate installed capacity of 22.32 MMTPA and are located in the states of West Bengal, Bihar, Odisha, Chhattisgarh, and Jharkhand in East India, and Rajasthan and Haryana in North India.

    Nuvoco Vistas IPO Details
    Subscription Dates 9-11 August 2021
    Price Band 560-570 Rs Per Share
    Offer For Sale 3500 crore
    Fresh issue 1500 crore
    Total IPO size 5,000 crore
    Minimum bid (lot size) 26 Rs Share
    Face Value 10 Rs share
    Retail Allocation 35%
    Listing On NSE, BSE
    Nuvoco Vistas Market Lot
    Lot No of Shares Amount
    Minimum 1 26 Shares 14,820 Rs
    Maximum 13 338 Shares 192,660 Rs

    Financial Record of the last year (In Million)

    Financial Period : 31-Mar-21
    Total Assets : 1,99,075.70
    Total Revenue : 75,226.93
    Profit After Tax : 259.19
    Earnings Per Share (EPS) FY2021 : -0.82

    Registrar of Nuvoco Vistas IPO

    Link Intime India Private Limited
    C-101, 1st Floor, 247 Park
    Lal Bahadur Shastri Marg,
    Vikhroli (West) Mumbai – 400 083
    Phone: +91 22 4918 6200
    Fax: +91 22 4918 6195
    Email: [email protected]
    Website: http://www.linkintime.co.in

    Nuvoco Vistas Contact Details

    Nuvoco Vistas Corporation Ltd
    Equinox Business Park, Tower 3, East Wing,
    4th Floor, LBS Marg, Kurla (West),
    Mumbai – 400 070
    Phone: +91 22 6769 2500
    Email: [email protected]
    Website: http://www.nuvoco.com/

    Rolex Rings IPO Date, Details, Price, GMP

    Upcoming IPO

    Rolex Rings is established in 2003 by Rupesh Dayashankar Madeka, Jiten Dayashankar Madeka, Manesh Dayashankar Madeka, Pinakin Dayashankar Madeka, and Bhautik Dayashankar Madeka are the company promoters.

    Rolex Rings is a global manufacturer and supplier of hot rolled forged and machined bearing rings, as well as automotive components for vehicle segments such as two-wheelers, passenger vehicles, commercial vehicles, off-highway vehicles, electric vehicles), industrial machinery, wind turbines, and railways.

    The firm sells its products to automotive companies and prominent bearing manufacturers on a domestic and worldwide scale, including SRF India, Schaeffler India, Timken India, and others. In fiscal 2020, it exported bearing rings and automobile components to 17 countries, including France, Italy, Germany, Thailand, the Czech Republic, the United States, and others.

    Currently, the company has three production units in Rajkot, each with 22 forging lines and a total installed capacity of 1,44,750 MTPA.

    Read :- Rolex Rings IPO GMP

    Rolex Rings IPO Competitive advantages

  • Among India’s biggest forging firms.
  • Excellent manufacturing capability.
  • A diverse product portfolio.
  • A revenue base that is geographically diverse.
  • A strong and consistent track record of financial achievement.
    • Rolex Rings IPO details
    Subscription Dates 28-30 July 2021
    Price Band 880-900 Rs Per Share
    Offer For Sale 675 crore
    Fresh issue 56 crore
    Total IPO size 731 crore
    Minimum bid (lot size) 16 Rs Share
    Face Value 10 Rs share
    Retail Allocation 35%
    Listing On NSE, BSE
    Rolex Rings Market Lot
    Lot No of Shares Amount
    Minimum 1 16 Shares 14,400 Rs
    Maximum 13 208 Shares 1,87,200 Rs

    Financial Record of the last year (In Million)

    Financial Period : 30-Sep-20
    Total Assets : 6,710.26
    Total Revenue : 2,254.59
    Profit After Tax : 253.14
    Earnings Per Share (EPS) FY2020 : 22.08 Rs

    Registrar of Rolex Ring IPO

    Link Intime India Private Limited
    C-101, 1st Floor, 247 Park
    Lal Bahadur Shastri Marg,
    Vikhroli (West) Mumbai – 400 083
    Phone: +91 22 4918 6200
    Fax: +91 22 4918 6195
    Email: [email protected]
    Website: http://www.linkintime.co.in

    Rolex Ring Contact Details

    Rolex Rings Limited
    B/h. Glowtech Steel Private Limited
    Gondal Road, Kotharia, Rajkot, 360 004
    Phone: 0281 6699677/577
    Email: [email protected]
    Website: http://www.rolexrings.com

    Tatva Chintan Pharma IPO Details

    Upcoming IPO

    Tatva Chintan Pharma Chem is established in 1996 by Ajaykumar Mansukhlal Patel, Chintan Nitinkumar Shah, and Snehkar Rasiklal Somani are the company promoters.

    Tatva Chintan Pharma Chem Limited produces structure directing agents (SDAs), phase transfer catalysts (PTCs), pharmaceutical and agricultural intermediates, and other speciality chemicals. It is one of India’s leading manufacturers of SDAs for zeolites. Automotive, petroleum, agrochemicals, dyes & pigments, paints and coatings, pharmaceutical, personal care, and other industries are served by the company. Its products are sold not just in India, but also in more than 25 countries throughout the world, including the United States, Germany, South Africa, China, and the United Kingdom. Total export provided 76 percent of total revenue from operations in FY 2020.

    Check :- IPO Allotment Status

    Among the company’s customers are Merck, Bayer AG, Ipox Chemicals, Laurus labs, Navin Fluorine International Limited, Atul Limited, Otsuka Chemicals, SRF Limited, Hawks Chemical Company, Firmenich Aromatics Prod Pvt Ltd, and Divi’s laboratories. It currently operates two manufacturing sites in Gujarat: Ankleshwar and Dahej.We have shared the details of tatva chintan pharma ipo and grey market premium gmp.

    Competitive advantages

  • Structure directing agents and phase transfer catalysts from a leading company.
  • Product portfolio with a wide range of options.
  • With a customer base spanning multiple industries, we have a global market presence.
  • A industrial complex in Gujarat that is strategically placed near the Hazira Port.
  • Team of seasoned promoters and managers.
  • A proven track record of financial success.
    • Tatva Chintan Pharma IPO details
    Subscription Dates 16-20 July 2021
    Price Band 1073-1083 Rs Per Share
    Offer For Sale 275 crore
    Fresh issue 225 crore
    Total IPO size 500 crore
    Minimum bid (lot size) 13 Rs Share
    Face Value 10 Rs share
    Retail Allocation 35%
    Listing On NSE, BSE
    Tatva Chintan Pharma Market Lot
    Lot No of Shares Amount
    Minimum 1 13 Shares 14,079 Rs
    Maximum 14 182 Shares 1,97,106 Rs

    Financial Record of the last year (In Million)

    Financial Period : 31-Mar-21
    Total Assets : 3,148.03
    Total Revenue : 3,062.92
    Profit After Tax : 522.62
    Earnings Per Share (EPS) FY2021 : 18.81 Rs

    Registrar of Tatva Chintan IPO

    Link Intime India Private Limited
    C-101, 1st Floor, 247 Park
    Lal Bahadur Shastri Marg,
    Vikhroli (West) Mumbai – 400 083
    Phone: +91 22 4918 6200
    Fax: +91 22 4918 6195
    Website: http://www.linkintime.co.in

    Tatva Chintan Contact Details

    Tatva Chintan Pharma Chem Limited
    Plot No. 353, Makarpura GIDC,
    Vadodara, Gujarat – 390 010
    Phone: +91 75748 48533
    Email: [email protected]
    Website: www.tatvachintan.com

    Zomato IPO Details,GMP, Allotment Status

    Upcoming IPO

    Zomato is an online food delivery platform founded by Pankaj Chaddah and Deepinder Goyal in 2008. Info Edge(18.6%),Uber (9.1%),Alipay Singapore (8.3%),Antfin Singapore (8.2%) are some current Share Holders of Zomato.

    There are 1,31,233 restaurants and 1,61,637 delivery partners connected with Zomato.

    Competitive advantages

  • Growing Customer Base
  • Top popular food delivery platforms
  • Consumer brand equity is well-known in India.
  • On-demand hyperlocal delivery network that is widespread and efficient.

    • News :- Info Edge reduces the size of Zomato IPO by half, to 375 crore

    Read Details :- Zomato raised Rs 4,196.51 crore from 186 anchor investors at Rs 76

    Read Details :- Zomato IPO GMP

    Read Details :- Zomato IPO Allotment Status

    Read Details :- Zomato Ltd IPO Subscription Status [Live]

    Key Risk

  • It has a history of net losses and anticipates increased expenses in the future
  • Covid-19 pandemic has had and could impact the business, cash flows, financial condition and results of operations.
  • Its revenue may decrease and the business may be adversely affected if it fails to retain existing restaurant partners, customers, or delivery partners or fails to add new restaurant partners, delivery partners, or customers to its portfolio in a cost-effective manner.
    • Zomato IPO details
    Subscription Dates 14-16 July 2021
    Price Band 72-76 Rs Per Share
    Offer For Sale 375 crore
    Fresh issue 9,000 crore
    Total IPO size 9,375 crore
    Minimum bid (lot size) 195 Rs Share
    Face Value 1 Rs share
    Retail Allocation 10%
    Listing On NSE, BSE
    Zomato Market Lot
    Lot No of Shares Amount
    Minimum 1 195 Shares 14820 Rs
    Maximum 13 2535 Shares 1,92,660 Rs

    Financial Record of the last year (In Million)

    Financial Period : 31-Dec-20
    Total Assets : 69,883.21
    Total Revenue : 13,676.55
    Profit After Tax : 6,821.99
    Earnings Per Share (EPS) FY2021 : -5.09 Rs

    Registrar of Zomato IPO

    Link Intime India Private Limited
    C-101, 1st Floor, 247 Park
    Lal Bahadur Shastri Marg,
    Vikhroli (West) Mumbai – 400 083
    Phone: +91 22 4918 6200
    Fax: +91 22 4918 6195
    Email: [email protected]
    Website: http://www.linkintime.co.in

    Zomato Contact Details

    Zomato Limited
    Ground Floor, Tower C,
    Vipul Tech Square, Golf Course Road,
    Sector 43, Gurgaon 122 009
    Phone: +91 124 426 8565
    Email: [email protected]
    Website: www.zomato.com

    Info Edge reduces the size of Zomato IPO by half, to 375 crore

    Upcoming IPO

    Zomato, an online restaurant discovery and food ordering service, is set to raise $1.2 billion in an initial public offering (IPO), paving the way for one of the most eagerly anticipated share sales in recent history.

    However, according to the market observers, Zomato IPO GMP (grey market premium) today is ₹15-20, which reflects the bullish expectations of the markets in regard to the construction company’s public issue.

    Info Edge, one of the largest shareholders in the food-delivery app Zomato, announced that it is reducing the size of its offer for sale (OFS) in Zomato’s IPO to 375 crore, down from 750 crore previously planned.

    Read :- Zomato IPO Details, Price, Date, GMP, Review

    Zomoto said The company’s revised OFS would consist of up to 3,750 million equity shares held by the company in Zomato, the terms and conditions of which will be specified in the red herring prospectus and the prospectus filed in relation to the offer, as well as other Offer related documents and agreements when an exchange filing on 4th July.

    In April, Zomato filed a draught red herring prospectus (DRHP) with market regulator SEBI, proposing an IPO of Rs 8,250 crore. According to the company, it will issue new equity shares worth Rs 7,500 crore, with early backer Info Edge India Ltd selling a stake worth Rs 750 crore in Zomato’s upcoming public offering.

    Glenmark Life Sciences IPO Details, Date, GMP, Review

    Upcoming IPO

    Glenmark Life Sciences Limited is established in 2011 by Glenmark Pharmaceuticals Limited are the promoters of the company.

    It is the world’s largest producer of Active Pharmaceutical Ingredients (APIs). The company creates, manufactures, and distributes high-quality APIs for cardiovascular disease (CVS), central nervous system disease (CNS), pain management, and diabetes, as well as gastrointestinal disorders, anti-infectives, and other therapeutic areas.

    It also provides contract development and manufacturing operations (CDMO) to specialty pharmaceutical companies.

    Updates :- Glenmark Life Sciences Limited IPO GMP / Grey market premium

    Its products are sold in India as well as in other countries such as Europe, North America, Latin America, Japan, and so on. It currently operates four manufacturing facilities in Gujarat (Ankleshwar and Dahej) and Maharashtra (Mohol and Kurkumbh), with an annual installed capacity of 725.8 KL as of December 31, 2020.

    Competitive advantages

  • Leading producer of specialised APIs for chronic therapeutic areas such as CVS, CNS, diabetes, and pain management.
  • Products can be exported to Europe, Latin America, North America, Japan, and the rest of the world.
  • Strong relationships with the world’s leading generic companies.
  • Proven track record of financial success.
  • Manufacturing of high-quality products with R&D infrastructure.
    • Glenmark Life Sciences Limited IPO details
    Subscription Dates 27-29 July 2021
    Price Band 695-720 Rs Per Share
    Offer For Sale 453.60 crore
    Fress Issue size 1,060 crore
    Total IPO size 1,513.60 crore
    Minimum bid (lot size) 20 Rs Share
    Face Value 2 Rs share
    Retail Allocation 35%
    Listing On NSE, BSE
    Glenmark Life Sciences Market Lot
    Lot No of Shares Amount
    Minimum 1 20 Shares 14400 Rs
    Maximum 13 260 Shares 187,200 Rs

    Financial Record of the last year (In Million)

    Financial Period : 31-Mar-21
    Total Assets : 19,970.75
    Total Revenue : 18,859.76
    Profit After Tax : 3,515.81
    Earnings Per Share (EPS) FY2021 : 32.61 Rs

    Registrar of Glenmark Life Sciences IPO

    KFintech Private Limited
    KFintech, Tower-B, Plot No 31 & 32,
    Financial District, Nanakramguda, Gachibowli,
    Hyderabad, Telangana India – 500 032.
    Phone: 04067162222, 04079611000
    Email: [email protected]
    Website: https://karisma.kfintech.com/
    Website: http://www.linkintime.co.in

    Glenmark Life Sciences Contact Details

    Glenmark Life Sciences Limited
    Plot No. 170-172, Chandramouli Industrial Estate,
    Mohol Bazarpeth, Solapur 413 213,
    Phone: +91 2189 234456/ +91 2189
    Email: [email protected]
    Website: http://www.glenmarklifesciences.com/